NeuroGen® is a nerve support supplement crafted by a top nerve surgeon with expertise in anti-aging and nutrition. NeuroGen® isn't just another health supplement—it is a targeted solution for those ...
The collaboration positions Neurogen at the forefront of globally building a scalable, home-based model for Alzheimer’s-related biomarker testing and cognitive-health services. Neurogen Biomarking and ...
Dr. Rany Aburashed, CEO of Neurogen Biomarking, dreams of revolutionizing Alzheimer's detection by making early, accessible testing the new standard of care. Inspired by his clinical, research, and ...
Alzheimer’s disease is not just a medical crisis. It is a human one. It affects nearly 7 million Americans today, yet the overwhelming majority are diagnosed only after the disease has taken hold.
Neurogen Biomarking is expanding its home-based Alzheimer’s testing model through a partnership with Tasso, which will supply its needle-free blood collection devices for use across Neurogen’s ...
BRANFORD, Conn. -- Feb 8, 2008 - Neurogen Corporation today updated the status of its later stage clinical portfolio and announced the future focus of its research efforts. Key elements of the update ...
Chief Executive Officer & Founder of Neurogen Biomarking. CHICAGO, May 01, 2025 (GLOBE NEWSWIRE) -- Neurogen Biomarking announced it is partnering with NeuroX, a venture of American TelePhysicians, to ...
BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (Nasdaq: NRGN - News), a drug development company focused on improved drugs for psychiatric and neurological disorders, today announced it has ...
OCEAN BEACH – Neurogen practitioner Shawna Joy Scott has moved her practice from Bay Park to Ocean Beach. Scott, the owner-operator of neurogenNOW, is the first to offer neurofeedback on the Peninsula ...
BRANFORD -- The loss of biotech darling Neurogen was considered an economic disaster for the town, but new tenants for the massive campus are on the way and a new landlord is drumming up even more ...
Investors Capital Partners, a Fairfield-based commercial real estate developer, has bought the Branford real estate of Neurogen Corp. for $3.5 million. This deal should close in the first quarter next ...
Ben Casavant, PhD, CEO & Co-Founder of Tasso Inc. The collaboration positions Neurogen at the forefront of globally building a scalable, home-based model for Alzheimer’s-related biomarker testing and ...